COVID’s Alarming Potential To Trigger Rare Paralysis Disorder Revealed
Researchers have found a concerning association between COVID-19 infection and an increased risk of developing the rare disorder Guillain-Barré syndrome over the following six weeks. However, the study authors, working with the American Academy of Neurology, also note those who received the Pfizer-BioNTech mRNA vaccine showed a lower risk of developing Guillain-Barré syndrome in comparison to others…
Share